Peptide libraries having enhanced subsequence diversity and methods for use thereof

US12595591B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12595591-B2
Application numberUS-202017622479-A
CountryUS
Kind codeB2
Filing dateJun 26, 2020
Priority dateJun 27, 2019
Publication dateApr 7, 2026
Grant dateApr 7, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present technology provides an approach to designing libraries of peptide sequences for discovery and testing of significantly more motifs than would be otherwise available in a given fixed library format. The technology includes a plurality of x-mers embedded in N-mer peptides sequences, where N and x are integers and where N is greater than x. This approach provides for the representation of multiple unique x-mer peptides in a single N-mer peptide feature.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for identifying a peptide binder, the method comprising: contacting a first sample with an engineered peptide library; selecting at least one of the plurality of peptides from the first subset of peptides; detecting a first signal output characteristic of an interaction of the sample with the engineered peptide library; and selecting the at least one peptide, which binds to the sample, based on the first signal output; wherein the engineered peptide library comprises: a plurality of peptide features, each of the peptide features including at least one peptide, the at least one peptide comprising a composite region having a defined sequence of amino acids of length N, the composite region representing k different elements, each of the different elements having defined sequence of amino acids of length x; wherein x, N and k are integers, x is less than N, k is at least 2 and is defined by the equation, k=N−x+1, a total number of different elements represented by the engineered peptide library is K Eng , the number of peptide features included in the engineered peptide library is F, and K Eng is at least 0.8*k*F. 2 . The method of claim 1 , wherein the first signal output is a fluorescence intensity obtained through fluorophore excitation-emission, the fluorescence intensity reflecting at least one of: i) an abundance of a component of one of the first sample and a second sample associated with the first plurality of peptides, and ii) a binding affinity of the component of one of the first sample and a second sample to the first plurality of peptides. 3 . The method of claim 1 , wherein the first sample comprises a receptor, antibody, enzyme, peptide, or an oligonucleotide. 4 . The method of claim 1 , wherein K Eng is at least 0.9*k*F. 5 . The method of claim 1 , wherein K Eng is at least 0.95*k*F. 6 . The method of claim 1 , wherein K Eng is at least 0.99*k*F. 7 . The method of claim 1 , wherein K Eng is at least 10*F. 8 . The method of claim 1 , wherein K Eng is at least 20*F. 9 . The method of claim 1 , wherein each of the elements in a selected one of the composite regions overlaps with each adjacent element in the composite region by at least 1 amino acid. 10 . The method of claim 1 , wherein the plurality of peptides represents at least 90% of a human proteome. 11 . The method of claim 1 , wherein N is at least 7 amino acids. 12 . The method of claim 1 , wherein N is at least 10 amino acids. 13 . The method of claim 1 , wherein N is at least 15 amino acids. 14 . The method of claim 1 , wherein x is at least 5 or at least 6.

Assignees

Inventors

Classifications

  • Design of libraries · CPC title

  • Detection of binding sites or motifs · CPC title

  • Libraries containing peptides or polypeptides, or derivatives thereof · CPC title

  • C40B30/04Primary

    by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding · CPC title

  • Isolating an individual clone by screening libraries · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12595591B2 cover?
The present technology provides an approach to designing libraries of peptide sequences for discovery and testing of significantly more motifs than would be otherwise available in a given fixed library format. The technology includes a plurality of x-mers embedded in N-mer peptides sequences, where N and x are integers and where N is greater than x. This approach provides for the representation…
Who is the assignee on this patent?
Roche Sequencing Solutions Inc
What technology area does this patent fall under?
Primary CPC classification C40B30/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).